Djoke Hendriks

Designing and Producing Modified, New-to-Nature Peptides with Antimicrobial Activity by Use of a Combination of Various Lantibiotic Modification Enzymes

Auke J. van Heel, Dongdong Mu, Manuel Montalbán‐López et al. · ACS Synthetic Biology · 2013 · 90 citations

Bioorganic Chemistry, Engineering, Peptide Engineering +21

Discovery, Production and Modification of Five Novel Lantibiotics Using the Promiscuous Nisin Modification Machinery

Auke J. van Heel, Tomas G. Kloosterman, Manuel Montalbán‐López et al. · ACS Synthetic Biology · 2016 · 87 citations · Full text

Bioorganic Chemistry, Engineering, Medicinal Chemistry +18

A novel bispecific antibody for EGFR-directed blockade of the PD-1/PD-L1 immune checkpoint

Iris Koopmans, Djoke Hendriks, Douwe F. Samplonius et al. · OncoImmunology · 2018 · 57 citations · Full text

Programmed Death Ligand 1 (PD-L1)-targeted TRAIL combines PD-L1-mediated checkpoint inhibition with TRAIL-mediated apoptosis induction

Djoke Hendriks, Yuan He, Iris Koopmans et al. · OncoImmunology · 2016 · 46 citations · Full text

Apoptosis, Immunology, Pd-l1 Checkpoint Inhibition +18

C-type lectin-like molecule-1 (CLL1)-targeted TRAIL augments the tumoricidal activity of granulocytes and potentiates therapeutic antibody-dependent cell-mediated cytotoxicity

Valerie R. Wiersma, Marco de Bruyn, Ce Shi et al. · mAbs · 2015 · 28 citations · Full text

Trail Augments, Immunology, Cell Death +16